Stock DNA
Pharmaceuticals & Biotechnology
JPY 14,112 Million (Small Cap)
11.00
NA
0.00%
0.08
4.58%
0.59
Revenue and Profits:
Net Sales:
5,920 Million
(Quarterly Results - Jun 2025)
Net Profit:
69 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.42%
0%
-5.42%
6 Months
-16.93%
0%
-16.93%
1 Year
-22.28%
0%
-22.28%
2 Years
-33.47%
0%
-33.47%
3 Years
-53.04%
0%
-53.04%
4 Years
-75.77%
0%
-75.77%
5 Years
-79.97%
0%
-79.97%
Japan Medical Dynamic Marketing, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.79%
EBIT Growth (5y)
-10.07%
EBIT to Interest (avg)
50.24
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.86
Tax Ratio
36.99%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.34%
ROE (avg)
7.30%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.60
EV to EBIT
9.54
EV to EBITDA
4.60
EV to Capital Employed
0.60
EV to Sales
0.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.28%
ROE (Latest)
5.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
5,920.10
6,655.20
-11.05%
Operating Profit (PBDIT) excl Other Income
548.50
738.60
-25.74%
Interest
43.00
29.90
43.81%
Exceptional Items
0.00
-1,778.40
100.00%
Consolidate Net Profit
68.70
-1,367.50
105.02%
Operating Profit Margin (Excl OI)
25.40%
49.00%
-2.36%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -11.05% vs 0.22% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 105.02% vs -444.98% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
25,114.00
23,177.70
8.35%
Operating Profit (PBDIT) excl Other Income
3,227.40
3,342.10
-3.43%
Interest
75.30
41.30
82.32%
Exceptional Items
-1,778.40
-155.60
-1,042.93%
Consolidate Net Profit
-469.10
1,305.50
-135.93%
Operating Profit Margin (Excl OI)
62.00%
75.40%
-1.34%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 8.35% vs 8.78% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -135.93% vs -9.07% in Mar 2024
About Japan Medical Dynamic Marketing, Inc. 
Japan Medical Dynamic Marketing, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






